On ECHEMI
Home > Drugs > Sudden deafness
Sudden deafness
Sudden deafness is also called idiopathic deafness or sudden deafness. It means that tinnitus and deafness occur suddenly and instantly without tinnitus and deafness, and hearing loss reaches a peak within a few hours or days. It usually affects one ear, with a high incidence in adults aged 40 to 60. Bilateral patients account for 1%, and are more common in men. It is more likely to occur in spring and autumn. According to statistics from Byl (1977), the incidence rate is 10.7/100,000. According to statistics from the hearing clinic of Beijing Tongren Hospital, it accounts for 4.8% of the first-time sensorineural hearing loss. According to recent domestic and foreign literature reports, this disease seems to be gradually increasing.
Related Drugs
Puerarin
Indication: Used as an auxiliary treatment for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, and sudden deafness.
Manufacturer:

Chengdu Tiantai Mountain Pharmaceutical Co., Ltd.

Puerarin
Indication: Used as an auxiliary treatment for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, and sudden deafness.
Manufacturer:

Hainan Haishen Tongzhou Pharmaceutical Co., Ltd.

Nimodipine
Indication: This product is used to prevent and treat ischemic nerve damage caused by cerebral vasospasm after subarachnoid hemorrhage, as well as senile brain function damage, migraine, sudden deafness, etc.
Manufacturer:

Xi'an Bo'ai Pharmaceutical Co., Ltd.

Puerarin Sodium Chloride Injection
Indication: Used for coronary heart disease, angina pectoris, myocardial infarction, retinal artery and vein occlusion, and sudden deafness.
Manufacturer:

Qingdao Jinfeng Pharmaceutical Co., Ltd.

Nimodipine Capsules
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.
Manufacturer:

Suzhou No.3 Pharmaceutical Factory Co., Ltd.

Nimodipine extended-release tablets
Indication: Used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness and mild to moderate hypertension.
Manufacturer:

Yabao Pharmaceutical Group Co., Ltd.

Nimodipine extended-release tablets
Indication: Used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness and mild to moderate hypertension.
Manufacturer:

Hubei Sihuan Pharmaceutical Co., Ltd.

Nimodipine Tablets
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.
Manufacturer:

Heilongjia PROVINCE Dina Pharmacy Co., Ltd.

Nimodipine Tablets
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.
Manufacturer:

Xi'an Bo'ai Pharmaceutical Co., Ltd.

Nimodipine Tablets
Indication: Calcium channel blockers are used for ischemic cerebrovascular disease, migraine, cerebral vasospasm caused by mild subarachnoid hemorrhage, sudden deafness, and mild to moderate hypertension.
Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.